on 10 Nov 2020
Last Applicant/ Owned by
8 CABOT ROAD, SUITE 2000
WOBURN
MA
01801
Serial Number
88439326 filed on 21st May 2019
Registration Number
6196161 registered on 10th Nov 2020
Correspondent Address
Douglas R. Wolf
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Pharmaceutical preparations sold as a kit for use by pharmacists and physicians in creating compounded hormone replacement medicines, topical anti-inflammatory and ultrasound gels, pain and gastrointestinal disorders treatment medicines, and anti-inflammatory, antimicrobial, and antifungal treatment medicines; medicines for the treatment of cardiovascular diseases and disorders, colitis, muscle spRead More
Pharmaceutical preparations sold as a kit for use by pharmacists and physicians in creating compounded hormone replacement medicines, topical anti-inflammatory and ultrasound gels, pain and gastrointestinal disorders treatment medicines, and anti-inflammatory, antimicrobial, and antifungal treatment medicines; medicines for the treatment of cardiovascular diseases and disorders, colitis, muscle spasm, infectious diseases, acid-reflux disease, ulcer disease, and urological disorders; antibiotics; pharmaceutical products for the treatment of pain, thyroid disorders, gastrointestinal disorders, gastroesophageal disorders, inflammation, infections, fungal diseases and disorders, cardiovascular diseases and disorders, colitis, muscle spasm, attention deficit hyperactivity disorders, infectious diseases, acid-reflux disease, ulcer disease, and urological disorders having vancomycin, enalapril, lisinopril, and methotrexate as the active pharmaceutical ingredient; antacids; muscle relaxants; hormone replacement medicines; topical anti-inflammatory and ultrasound gels; pharmaceutical preparation for the treatment of pain, thyroid disorders, gastrointestinal disorders, gastroesophageal disorders, inflammation, infections, fungal diseases and disorders, cardiovascular diseases and disorders, colitis, muscle spasm, attention deficit hyperactivity disorders, infectious diseases, acid-reflux disease, ulcer disease, and urological disorders; pharmaceuticals for use in the treatment of cancer and autoimmune diseases and disorders, and for the treatment and prevention of renal, oncological, inflammatory, gastrointestinal, gastroesophageal, and cardio-vascular diseases and disorders
31st Aug 2020
31st Aug 2020
No 88439326
No Service/Collective Mark
No C10472002900
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 10th Nov 2020 | REGISTERED-PRINCIPAL REGISTER |
| 08th Oct 2020 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 07th Oct 2020 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 02th Oct 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 02th Oct 2020 | STATEMENT OF USE PROCESSING COMPLETE |
| 17th Sep 2020 | TEAS STATEMENT OF USE RECEIVED |
| 17th Sep 2020 | USE AMENDMENT FILED |
| 29th Apr 2020 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| 28th Apr 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 03rd Mar 2020 | PUBLISHED FOR OPPOSITION |
